The FARAPULSE FARA-Freedom Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT05072964
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT05072964
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Czechia, Denmark, Germany, Netherlands, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT05072964. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-21 (actual); primary completion 2023-10-12 (actual). Results posted on 2024-10-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The FARAPULSE FARA-Freedom Trial
- Acronym
- FARA-Freedom
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- FARAPULSE Pulsed Field Ablation System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct05072964- Content hash
7b4e8797ba83b50e2f273e2de911bf8b57ff982f81d66578c8b31437534bb8a8